Hyperforin modifies neuronal membrane properties in vivo

Neuroscience Letters

Volumn 367, Issue 2, 2004, Pages 139-143

  Eckert, Gunter P ^a   Keller, Jan Henning ^a   Jourdan, Claudia ^a   Karas, Michael ^a   Volmer, Dietrich A ^b   Schubert Zsilavecz, Manfred ^a   Müller, Walter E ^a  

^a GOETHE UNIVERSITY   (Germany)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Brain; Fluidity; HPLC; Hyperforin; Hypericum perforatum; Membrane; MS; St. John's Wort

Indexed keywords

HYPERFORIN; HYPERICUM PERFORATUM EXTRACT; SODIUM;

ARTICLE; BRAIN MEMBRANE; CELL MEMBRANE FLUIDITY; CONTROLLED STUDY; DRUG BRAIN LEVEL; MOUSE; NERVE CELL MEMBRANE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANISOTROPY; BICYCLO COMPOUNDS; BRAIN; BRAIN CHEMISTRY; CELL MEMBRANE; CHROMATOGRAPHY, LIQUID; DIPHENYLHEXATRIENE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYPERICUM; MEMBRANE FLUIDITY; MICE; NEURONS; PHLOROGLUCINOL; PLANT EXTRACTS; PYRENES; TERPENES;

EID: 4344589885     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.04.053     Document Type: Article

References (21)

1. Biber A., Fischer H., Romer A., Chatterjee S.S. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers. Pharmacopsychiatry. 31(1):1998;36-43
2. Cervo L., Rozio M., Ekalle-Soppo C.B., Guiso G., Morazzoni P., Caccia S. Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts. Psychopharmacology. 164:2002;423-428
3. Chatterjee S., Filippov V., Lishko P., Maximyuk O., Nöldner M., Krishtal O. Hyperforin attenuates various ionic conductance mechanisms in the isolated hippocampal neurons of rat. Life Sci. 65:1999;2395-2405
4. Davies P.F. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 75:1995;519-560
5. Eckert G.P., Müller W.E. Effects of hyperforin on the fluidity of brain membranes. Pharmacopsychiatry. 34(Suppl. 1):2001;S22-S25
6. 2+ mobilization and functional leukocyte respones by hyperforin. Biochem. Pharmacol. 67:2004;1531-1539
7. Fox E., Murphy R.F., McCully C.L., Adamson P.C. Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primates. Cancer Chemother. Pharmacol. 47:2001;41-44
8. Gudi S., Nolan J.P., Frangos J.A. Modulation of GTPase activity of G-proteins by fluid shear stress and phospholipid composition. Proc. Natl. Acad. Sci. USA. 95:1998;2515-2519
9. Kaiser R.D., London E. Location of diphenylhexatriene (DPH) and its derivatives within membranes: comparison of different fluorescence quenching analyses of membrane depth. Biochemistry. 37:1998;8180-8190
10. Keller J.H., Karas M., Müller W.E., Volmer D.A., Eckert G.P., Tawab M.A., Blume H.H., Dingermann T., Schubert-Zsilavecz M. Determination of hyperforin in mouse brain by high-performance liquid chromatography/tandem mass spectrometry. Anal. Chem. 75:2003;6084-6088
11. Krishtal O., Lozovaya N., Fisunov A., Tsintsadze T., Pankratov Y., Kopanitsa M., Chatterjee S.S. Modulation of ion channels in rat neurons by the constituents of Hypericum perforatum. Pharmacopsychiatry. 34(Suppl. 1):2001;S74-S82
12. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275
13. Mitchell D.C., Niu S.L., Litman B.J. Enhancement of G-protein-coupled signaling by DHA phospholipids. Lipids. 38:2003;437-443
14. Mulders F., van Langen H., Van Ginkel G., Levine Y.K. The static and dynamic behaviour of fluorescent probe molecules in lipid bilayers. Biochim. Biophys. Acta. 859:1986;209-218
15. Müller W.E. Current St. John's wort research from mode of action to clinical efficacy. Pharmacol. Res. 47:2003;101-109
16. Ropero S., Chiloeches A., Montes A., Toro-Nozal M.J. Cholesterol cell content modulates GTPase activity of G proteins in GH4C1 cell membranes. Cell Signal. 15:2003;131-138
17. Serdarevic N., Eckert G.P., Müller W.E. The effects of extracts from St. John's Wort and Kava Kava on brain neurotransmitter levels in the mouse. Pharmacopsychiatry. 34(Suppl. 1):2001;S134-S136
18. +]. J. Pharmacol. Exp. Ther. 290:1999;1363-1368
19. Treiber K., Singer A., Müller W.E. Activation of nonselective cation channes by Hyperforin - a novel mechanism of antidepressant activity. Soc. Neurosci. Abstr. 29:2003;851
20. Wonnemann M., Singer A., Siebert B., Müller W.E. Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort. Pharmacopsychiatry. 34(Suppl. 1):2001;S148-S151
21. Wood W.G., Eckert G.P., Igbavboa U., Müller W.E. Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease. Biochim. Biophys. Acta. 1610:2003;281-290